CorMedix Inc. (CRMD) Financials
CRMD Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 815.6 million | 378.6 million |
| Dec. 31, 2025 | 826.1 million | 420.8 million |
| Sept. 30, 2025 | 750.9 million | 376.7 million |
| June 30, 2025 | 252.6 million | 32.0 million |
CRMD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 41.7 million | 4.6 million |
| Dec. 31, 2025 | 94.4 million | 9.7 million |
| Sept. 30, 2025 | 30.4 million | 4.1 million |
| June 30, 2025 | 30.0 million | 2.7 million |
CRMD Net Income
No data available :(
CRMD Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 178.1 million | 144.9 million | - |
| Dec. 31, 2025 | 149.5 million | 144.6 million | 4.3 million |
| Sept. 30, 2025 | 55.7 million | 144.5 million | 4.4 million |
| June 30, 2025 | 190.7 million | - | 435245 |
CRMD Shares Outstanding
CRMD Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 729000 | 7.2 million | 34.3 million | 12.5 million |
| Dec. 31, 2025 | 44299 | 8.6 million | 39.6 million | 16.0 million |
| Sept. 30, 2025 | 505774 | 5.1 million | 36.6 million | 11.2 million |
| June 30, 2025 | 23945 | 2.4 million | 15.9 million | 6.4 million |
CRMD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 127.4 million | 22.3 million |
| Dec. 31, 2025 | 128.6 million | 21.3 million |
| Sept. 30, 2025 | 104.3 million | 11.2 million |
| June 30, 2025 | 39.7 million | 1.9 million |
CRMD Revenue by Segment
Graph available only for paid members. Upgrade to see it.
CRMD
Price: $8.59
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.17 USD
P/E Ratio: 3.60
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 278900
Market Capitalization: 655.9 million